Class of Stock [Axis]
Series A Redeemable Convertible Preferred Stock [Member]
Product and Service [Axis]
Net Product Revenues [Member]
Research and Development Revenues [Member]
Grant Income [Member]
Collaboration Arrangement Income [Member]
License and Other Revenues [Member]
Equity Components [Axis]
Temporary Equity [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Loan Agreements [Member]
Timing of Transfer of Good or Service [Axis]
Transferred at Point in Time [Member]
Transferred over Time [Member]
Ownership [Axis]
Theon International Plc [Member]
Kopin Europe, Ltd. [Member]
Kopin Corporation [Member]
Joint Development & License Agreement [Member]
Related and Nonrelated Parties [Axis]
Fabric.AI, Inc. [Member]
Convertible Preferred Stock [Member]
Financial Instrument [Axis]
Money Market Fund Holdings Included In Cash Equivalents [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Certificates of Deposit [Member]
Equity Investments [Member]
Other Receivable [Member]
Asset Class [Axis]
Equity Method Investments [Member]
Investment, Name [Axis]
RealWear, Inc. [Member]
Solos Inc [Member]
HMD md [Member]
Lenovo New Vision [Member]
Global Communication Semiconductors, Inc [Member]
Measurement Input Type [Axis]
Measurement Input, Expected Term [Member]
Measurement Input, Risk Free Interest Rate [Member]
Measurement Input, Price Volatility [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Measurement Input, Expected Dividend Rate [Member]
Corporate Debt [Member]
Antidilutive Securities [Axis]
Restricted Stock [Member]
Stock Options [Member]
Securities Purchase Agreement [Member]
Sale of Stock [Axis]
Private Investment in Public Equity Financing [Member]
Title and Position [Axis]
Chief Executive Officer [Member]
Award Type [Axis]
Equity Option [Member]
Location, Statement of Income, Balance [Axis]
Segments [Axis]
Single Reportable Segment [Member]
Geographical [Axis]
UNITED STATES
Other Americas [Member]
Americas [Member]
Asia Pacific [Member]
Europe [Member]
Defense [Member]
Industrial [Member]
Medical [Member]
Consumer and other product [Member]
Net Product Revenues [Member]
R&D [Member]
License and Royalties [Member]
ASC 606 Revenues [Member]
Grant [Member]
Collaboration [Member]
Non ASC 606 Revenues [Member]
Mutual Release Agreement [Member]
Supply Display Modules Agreement [Member]
HMDmd, Inc. [Member]
Subscription Agreement [Member]
Share Repurchase Agreement [Member]
Lightning Silicon Technology, Inc.[Member]
Series Seed-1 Preferred Stock [Member]
LS Assets, Inc. [Member]
Individual [Axis]
Paul C. Baker [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Listing, Par Value Per Share
Statement [Table]
Statement [Line Items]
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash and cash equivalents
Accounts receivable, net of allowance of $19,300 and $19,000 at June 27, 2026 and December 27, 2025, respectively
Contract assets
Grant income receivable
Inventory
Other receivable, at fair value
Prepaid expenses and other current assets
Total current assets
Property, plant and equipment, net
Operating lease right-of-use assets
Other assets
Equity method investment, at fair value
Equity investments
Total assets
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued payroll and expenses
Accrued warranty
Contract liabilities
Deferred grant income
Operating lease liabilities
Accrued post-retirement benefits
Other accrued liabilities
Deferred tax liabilities
Accrued litigation damages
Total current liabilities
Non-current contract liabilities, and asset retirement obligations
Operating lease liabilities, net of current portion
Accrued post-retirement benefits, net of current portion
Other long-term liabilities, net of current portion
Total liabilities
Commitments and contingencies (Note 16) and Litigation (Note 17)
Series A redeemable convertible preferred stock, par value $0.01, stated value $7,000 per share; 3,000 shares authorized, no shares issued and outstanding as of June 27, 2026 and 1,000 shares issued and outstanding at December 27, 2025; aggregate liquidation preference of $7,000,000 as of December 27, 2025
Stockholders’ equity:
Common stock, par value $0.01; 275,000,000 shares authorized as of June 27, 2026 and December 27, 2025, 186,974,903 issued as of June 27, 2026 and 183,015,207 issued as of December 27, 2025, and 180,618,566 outstanding at June 27, 2026 and 176,903,857 at December 27, 2025
Additional paid-in capital
Treasury stock 1,102,289 shares at June 27, 2026 and 771,500 shares at December 27, 2025, at cost
Accumulated deficit
Total stockholders’ equity
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity
Accounts receivable, allowance
Temporary equity, par or stated value per share
Temporary equity, par value
Temporary equity, shares authorized
Temporary equity, shares issued
Temporary equity, shares outstanding
Temporary equity, liquidation preference
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Treasury stock, shares
Revenues:
Total revenues
Expenses:
Cost of product revenues
Research and development – Funded
Research and development – Internal
Selling, general and administrative
Total operating expenses
Loss from operations
Non-operating income (expense), net:
Interest income
Other (expense) income, net
Foreign currency transaction gains
Loss on impairment of investments, net
Gain on investments
Total non-operating income
Loss before provision for income taxes
Benefit (provision) for income taxes
Net income (loss)
Net income (loss) per share attributable to common stockholders:
Basic
Diluted
Weighted average number of common shares outstanding:
Basic
Diluted
Income Statement [Abstract]
Net income (loss)
Other comprehensive income, net of tax:
Foreign currency translation adjustments
Unrealized holding (loss) gain on marketable securities
Other comprehensive income, net of tax
Comprehensive income (loss)
Balance
Balance, shares
Stock-based compensation expense
Dividend on Series A Redeemable Convertible Preferred Stock
Net loss
Prefunded warrant exercise
Prefunded warrant exercise, shares
Conversion of preferred stock into common stock
Conversion of preferred stock into common stock, shares
Vesting of restricted stock
Vesting of restricted stock, shares
Restricted stock for withholding obligations
Other comprehensive Income (loss)
Balance
Balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Net loss
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation
Loss on sale of property and equipment
Non-cash (gain) loss on equity investments
Gain on sale of equity investment
Income taxes
Foreign currency gains
Provision for bad debt
Noncash provision for excess inventory
Changes in assets and liabilities:
Accounts receivable
Contract assets
Grant Income Receivable
Inventory
Prepaid expenses and other current assets
Other receivable
Accounts payable and accrued expenses
Accrued warranty
Contract liabilities
Deferred collaboration arrangement income
Deferred grant income
Net cash used in operating activities
Cash flows from investing activities:
Proceeds from sale of marketable securities
Proceeds from sale of equity investment
Capital expenditures
Purchases of marketable securities
Other assets
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Settlements of restricted stock for tax withholding obligations
Conversion of preferred stock
Exercise of prefunded warrant
Net cash provided by financing activities
Effect of exchange rate changes on cash
Net change in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Trading Arrangements, by Individual [Table]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION
Accounting Policies [Abstract]
ACCOUNTING STANDARDS
Investments, All Other Investments [Abstract]
STRATEGIC INVESTMENT FROM THEON
Joint Development And License Agreement With Fabric.ai
JOINT DEVELOPMENT AND LICENSE AGREEMENT WITH FABRIC.AI
FINANCIAL INSTRUMENTS
Credit Loss [Abstract]
ACCOUNTS RECEIVABLE, NET
Inventory Disclosure [Abstract]
INVENTORY
Earnings Per Share [Abstract]
NET LOSS PER SHARE
Equity [Abstract]
SERIES A CONVERTIBLE PREFERRED STOCK
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION
Guarantees and Product Warranties [Abstract]
ACCRUED WARRANTY
Income Tax Disclosure [Abstract]
INCOME TAXES
Contract Assets And Liabilities
CONTRACT ASSETS AND LIABILITIES
Leases
LEASES
Segment Reporting [Abstract]
SEGMENTS AND DISAGGREGATION OF REVENUE
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
LITIGATION
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Recently Issued Accounting Pronouncements
SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATIONS
SCHEDULE OF FAIR VALUE MEASUREMENTS OF FINANCIAL ASSETS
SCHEDULE OF CHANGES IN FINANCIAL ASSETS MEASURED AT FAIR VALUE
SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES
SCHEDULE OF EQUITY INVESTMENTS
SCHEDULE OF ACCOUNTS RECEIVABLE
SCHEDULE OF CHANGE IN ALLOWANCE FOR CREDIT LOSSES
SCHEDULE OF INVENTORY
SCHEDULE OF WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE
SCHEDULE OF STOCK OPTIONS WEIGHTED AVERAGE OF ASSUMPTIONS
SUMMARY OF STOCK OPTION ACTIVITY
SCHEDULE OF ACCRUED WARRANTY
SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY
SCHEDULE OF LEASE EXPENSE
SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASES
SCHEDULE OF OPERATING LEASE LIABILITIES RECOGNIZED IN CONSOLIDATED BALANCE SHEETS
SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES
SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS
SCHEDULE SEGMENT INFORMATION BY REVENUE TYPE
SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT
SCHEDULE OF REVENUE WITH RELATED PARTIES
Disaggregation of Revenue [Table]
Disaggregation of Revenue [Line Items]
Revenue percentage from products and services transferred customers
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net loss
Net cash outflows from operations
Damages paid value
Awarded value
Litigation settlement, gain
Payments for legal settlements
Professional fees
Remaining performance obligation
Revenue, remaining performance obligation, amount subject to cancellation
InvestmentDisclosureTable [Table]
Payments to acquire interest in subsidiaries
Ownership interest percentage
Purchase of stock
Purchase of shares
Preferred stock, par value
Committed fund
Collaboration revenue
Development activities
Committed fund received
Equity investment at fair value
Research and development revenues
Deferred collaboration arrangement income
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Financial instruments, owned, at fair value
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
Beginning balance
Additions
Gain (Loss) from changes in fair value
Ending balance
FinancialInstrumentsTable [Table]
Deposit and restricted cash
Equity method investments
Asset, Impairment Loss
Ownership percentage
Investments
Impairment on investment
Equity investment
Equity investments at fair value input
Ownership percentage
Investment interest rate
Discount rate percentage
Investment owned, fair value
Interest rate percentage
Outstanding balance
Debt securities, trading, measurement input
Amortized Cost
Unrealized Gains/(Losses)
Fair Value
Impairment Effects on Earnings Per Share [Table]
Impairment Effects on Earnings Per Share [Line Items]
Equity investments – measurement alternative
Equity investments – equity-method accounting, at fair value
Equity investments – at fair value
Equity investments
Accounts receivable
Less — allowance for credit losses
Total
Balance, December 27, 2025
Write-offs
Additions charged to operations
Balance, June 27, 2026
Raw materials
Work-in-process
Finished goods
Total
Weighted average common shares outstanding-basic
Stock options and non-vested restricted common stock
Weighted average common shares outstanding-diluted
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total
Stock, Class of Stock [Table]
Class of Stock [Line Items]
Temporary Equity, Shares Authorized
Temporary Equity, Par or Stated Value Per Share
[custom:TemporaryEquitySharesDesignated-0]
Conversion shares
Conversion price
Temporary Equity, Shares Issued
Temporary Equity, Shares Outstanding
Number of issued and sold
Sale of stock price per share
Shares, Non-vested
Weighted Average Grant Date Fair Value, Non-vested
Grant-Date Fair Value, Non-vested
Shares, Non-vested Granted
Weighted Average Grant Date Fair Value, Non-vested Granted
Grant-Date Fair Value, Non-vested Granted
Shares, Non-vested Forefeited
Weighted Average Grant Date Fair Value, Non-vested Forfeited
Grant-Date Fair Value, Non-vested Forfeited
Shares, Non-vested Vested
Weighted Average Grant Date Fair Value, Non-vested Vested
Grant-Date Fair Value, Non-vested Vested
Shares, Non-vested
Weighted Average Grant Date Fair Value, Non-vested
Grant-Date Fair Value, Non-vested
Shares, Non-vested Expected to vest
Weighted Average Grant Date Fair Value, Non-vested Expected to vest
Grant-Date Fair Value, Non-vested Expected to vest
CompensationRelatedCostsTable [Table]
Total
Average risk-free interest rate
Expected dividend yield
Expected life (average, in years)
Expected volatility
Weighted average exercise price
Weighted average fair value
Number of Options, Outstanding Beginning
Weighted Average Exercise Price, Outstanding Beginning
Intrinsic Value, Outstanding Beginning Balance
Number of Options, Granted
Weighted Average Exercise Price, Granted
Number of Options, Outstanding Ending
Weighted Average Exercise Price, Outstanding Ending
Intrinsic Value Outstanding, Ending balance
Number of Options, Option Exercisable Ending
Weighted Average Exercise Price, Outstanding Exercisable
Intrinsic Value, Option Exercisable
Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued
Net proceeds from the offering
Unrecognized compensation expense
Weighted average period
Option granted
Strike price
Vesting period
Product Warranty Liability [Table]
Product warranty term
Balance, December 27, 2025
Additions
Claims
Balance, June 27, 2026
Income tax expense benefit
Operating loss carryforwards
Operating loss carryforwards, limitations on use
Operating loss carryforwards not subject to expiration
Schedule Of Contract With Customer Asset And Liability
ASC 606 Contract assets
ASC 606 Current contract liabilities and billings in excess of revenue earned
ASC 606 Noncurrent contract liabilities
Grant income receivable
Collaboration contract assets (recorded in Prepaid expenses and other current assets)
Deferred grant income
Increase (decrease) in net contract assets
Increase (decrease) in contract liabilities
Revenue related to its contract liabilities
Grant income receivable
Grant income receivable
Schedule Of Lease Expense
Operating lease cost
Schedule Of Future Lease Payment Under Non-cancellable Leases
2026 (excluding the six months ended June 27,2026)
2027
2028
2029
2030
Total future lease payments
Less effects of discounting
Total
Operating lease liabilities–current
Operating lease liabilities–noncurrent
Total lease liabilities
Cash paid for amounts included in the measurement of operating lease liabilities
Weighted Average Discount Rate - Operating Leases
Weighted Average Remaining Lease Term-Operating Leases (in years)
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Table]
Long lived assets
Segment Reporting [Table]
Segment Reporting [Line Items]
Total Revenues
Percentage of total revenue
Number of operating segments
Number of reportable segments
Damages
Pre-judgment interest
Fee and costs
Damages sought, value
Loss Contingency, Damages Paid, Value
Recognized benefit
Accured legal expenses
Payments for Legal Settlements
Professional Fees
Deposit Assets
Accrued litigation liability
Other accrued liabilities
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Revenue
Purchases
Receivables with related parties
Payables with related parties
License fees and royalties
Owned percentage
Number of warrants to purchase preferred stock
Subscribed ordinary shares
Share Repurchase Program, Authorized, Number of Shares
Share Price
Grant income receivable.
Equity method investments non current.
Equity investments.
Series A Redeemable Convertible Preferred Stock [Member]
Research and development funded.
Loss on impairment of investments, net.
Temporary Equity [Member]
Conversion of preferred stock into common stock value.
Conversion of preferred stock into common stock shares.
Noncash provision for excess inventory.
Accrued warranty.
Deferred grant income.
Accrued dividends.
Loan Agreements [Member]
Revenue percentage from products and services transferred customers.
Revenue remaining performance obligation amount subject to cancellation.
Theon International Plc [Member]
Kopin Europe, Ltd. [Member]
Kopin Corporation [Member]
Joint Development and License Agreement [Text Block]
Joint Development & License Agreement [Member]
Fabric.AI, Inc. [Member]
Other Receivable [Member]
Corporate Debt [Member]
Available For Sales Securities [Text Block]
Equity investments – measurement alternative.
Equity investments – equity-method accounting, at fair value.
Equity investments – available-for-sale.
Equity method investment.
RealWear, Inc. [Member]
Solos Inc [Member]
HMD md [Member]
Lenovo New Vision [Member]
Global Communication Semiconductors, Inc [Member]
Convertible preferred stock (as converted to common stock.
Securities Purchase Agreement [Member]
Private Investment in Public Equity Financing [Member]
Number of Restricted shares fully vested and expected to vest during period.
Share based compensation arrangement by share based payment award equity instruments other than options vested weighted average grant date fair value.
Share-based compensation arrangement by share-based payment award, equity instruments other than options in period, fair value.
Share-based compensation arrangement by share-based payment award, equity instruments other than options, granted in period, fair value.
Share-based compensation arrangement by share-based payment award, equity instruments other than options forfeited in period, fair value.
Share based compensation arrangement by share based payment award equity instruments other than options in period total fair value vest.
Contract Assets Liabilities [Text Block]
Contract with customer liability grant income receivable.
Increase decrease in net contract assets.
Increase decrease in contract liabilities.
Increase decrease in grant income receivables.
Schedule of Operating Lease Payments Recognized in Consolidated Balance Sheets [Table Text Block]
Schedule of Supplemental Information Related to Leases [Table Text Block]
Other Americas [Member]
Percentage of total revenue.
Mutual Release Agreement [Member]
Supply Display Modules Agreement [Member]
Percentage owned of an equity investment.
HMDmd, Inc. [Member]
Subscription Agreement [Member]
Lightning Silicon Technology, Inc.[Member]
Share Repurchase Agreement [Member]
Series Seed-1 Preferred Stock [Member]
LS Assets, Inc. [Member]
Net Product Revenues [Member]
Research and Development Revenues [Member]
Grant Income [Member]
Collaboration Arrangement Income [Member]
License and Other Revenues [Member]
Money Market Fund Holdings Included In Cash Equivalents [Member]
Equity Investments [Member]
Loan Receivable [Member]
Stock Options [Member]
Defense [Member]
Industrial [Member]
Medical [Member]
Consumer and other product [Member]
Net Product Revenues [Member]
R&D [Member]
License and Royalties [Member]
ASC 606 Revenues [Member]
Collaboration [Member]
Non ASC 606 Revenues [Member]
Paul C. Baker [Member]
Michael Murray [Member]
Single Reportable Segment [Member]
Fair value measurement additions.
Net Product Revenues [Member] [Default Label]
Assets, Current
Assets
Liabilities, Current
Liabilities
Treasury Stock, Value
Equity, Attributable to Parent
Liabilities and Equity
Operating Expenses
Operating Income (Loss)
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Income Tax Expense (Benefit)
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
Equity, Including Portion Attributable to Noncontrolling Interest
Shares, Outstanding
Stock Redeemed or Called During Period, Value
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation
Gain (Loss) on Disposition of Property Plant Equipment
Equity Method Investment, Realized Gain (Loss) on Disposal
Gain (Loss) on Sale of Investments
Gain (Loss), Foreign Currency Transaction, before Tax
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Contract with Customer, Asset
Increase (Decrease) in Income Taxes Receivable
Increase (Decrease) in Inventories
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Other Receivables
IncreaseDecreaseInAccruedWarranty
Increase (Decrease) in Contract with Customer, Liability
DeferredGrantIncome
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Marketable Securities
Payment for (Proceeds from) Other Investing Activity
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Payment, Tax Withholding, Share-Based Payment Arrangement
Payments for Repurchase of Convertible Preferred Stock
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Net Income (Loss) Available to Common Stockholders, Basic
Deferred Compensation Liability, Current
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
Accounts Receivable, Allowance for Credit Loss, Writeoff
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodTotalFairValue
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsVestedAndExpectedToVestOutstandingNumber
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsvestedWeightedAverageGrantDateFairValue
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodTotalFairValueVest
Share-Based Payment Arrangement, Expense
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Standard Product Warranty Accrual
Standard Product Warranty Accrual, Increase for Warranties Issued
Standard Product Warranty Accrual, Decrease for Payments
Contract with Customer, Liability, Noncurrent
ContractWithCustomerLiabilityGrantIncomeReceivable
IncreaseDecreaseInGrantIncomeReceivables
Increase (Decrease) in Deferred Income Taxes
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Operating Lease, Liability
Other Accrued Liabilities, Noncurrent